Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | 5-HETE | cPLA2i | 1.0 | BCD110605C16 | 0.608 | pmol/ml of medium |
| - | 5-HETE | cPLA2i | 1.0 | BCD110605C18 | 0.628 | pmol/ml of medium |
| - | 5-HETE | cPLA2i | 1.0 | BCD110605C17 | 0.44 | pmol/ml of medium |
| - | 5-HETE | cPLA2i | 4.0 | BCD110605C34 | 0.526 | pmol/ml of medium |
| - | 5-HETE | cPLA2i | 4.0 | BCD110605C36 | 0.43 | pmol/ml of medium |
| - | 5-HETE | cPLA2i | 4.0 | BCD110605C35 | 0.452 | pmol/ml of medium |
| - | 5-HETE | cPLA2i | 20.0 | BCD110605C53 | 0.198 | pmol/ml of medium |
| - | 5-HETE | cPLA2i | 20.0 | BCD110605C54 | 0.155 | pmol/ml of medium |
| - | 5-HETE | cPLA2i | 20.0 | BCD110605C52 | 0.228 | pmol/ml of medium |
| - | 5-HETE | PLDi | 1.0 | BCD110605C10 | 0.667 | pmol/ml of medium |
| - | 5-HETE | PLDi | 1.0 | BCD110605C12 | 0.687 | pmol/ml of medium |
| - | 5-HETE | PLDi | 1.0 | BCD110605C11 | 0.543 | pmol/ml of medium |
| - | 5-HETE | PLDi | 4.0 | BCD110605C30 | 0.519 | pmol/ml of medium |
| - | 5-HETE | PLDi | 4.0 | BCD110605C29 | 0.599 | pmol/ml of medium |
| - | 5-HETE | PLDi | 4.0 | BCD110605C28 | 0.687 | pmol/ml of medium |
| - | 5-HETE | PLDi | 20.0 | BCD110605C48 | 0.26 | pmol/ml of medium |
| - | 5-HETE | PLDi | 20.0 | BCD110605C47 | 0.226 | pmol/ml of medium |
| - | 5-HETE | PLDi | 20.0 | BCD110605C46 | 0.263 | pmol/ml of medium |
| - | 5-HETE | KDO+cPLA2i | 1.0 | BCD110605C19 | 0.659 | pmol/ml of medium |
| - | 5-HETE | KDO+cPLA2i | 1.0 | BCD110605C21 | 0.738 | pmol/ml of medium |
| - | 5-HETE | KDO+cPLA2i | 1.0 | BCD110605C20 | 0.897 | pmol/ml of medium |
| - | 5-HETE | KDO+cPLA2i | 4.0 | BCD110605C39 | 1.43 | pmol/ml of medium |
| - | 5-HETE | KDO+cPLA2i | 4.0 | BCD110605C37 | 1.28 | pmol/ml of medium |
| - | 5-HETE | KDO+cPLA2i | 4.0 | BCD110605C38 | 1.62 | pmol/ml of medium |
| - | 5-HETE | KDO+cPLA2i | 20.0 | BCD110605C55 | 1.89 | pmol/ml of medium |
| - | 5-HETE | KDO+cPLA2i | 20.0 | BCD110605C57 | 2.01 | pmol/ml of medium |
| - | 5-HETE | KDO+cPLA2i | 20.0 | BCD110605C56 | 1.42 | pmol/ml of medium |
| - | 5-HETE | KDO+PLDi | 1.0 | BCD110605C15 | 1.45 | pmol/ml of medium |
| - | 5-HETE | KDO+PLDi | 1.0 | BCD110605C14 | 1.28 | pmol/ml of medium |
| - | 5-HETE | KDO+PLDi | 1.0 | BCD110605C13 | 1.47 | pmol/ml of medium |
| - | 5-HETE | KDO+PLDi | 4.0 | BCD110605C32 | 2.48 | pmol/ml of medium |
| - | 5-HETE | KDO+PLDi | 4.0 | BCD110605C31 | 2.46 | pmol/ml of medium |
| - | 5-HETE | KDO+PLDi | 4.0 | BCD110605C33 | 2.68 | pmol/ml of medium |
| - | 5-HETE | KDO+PLDi | 20.0 | BCD110605C49 | 2.04 | pmol/ml of medium |
| - | 5-HETE | KDO+PLDi | 20.0 | BCD110605C51 | 2.59 | pmol/ml of medium |
| - | 5-HETE | KDO+PLDi | 20.0 | BCD110605C50 | 3.67 | pmol/ml of medium |
| - | 5-HETE | KDO + ATP | 1.0 | BCD110605C07 | 1.19 | pmol/ml of medium |
| - | 5-HETE | KDO + ATP | 1.0 | BCD110605C09 | 1.24 | pmol/ml of medium |
| - | 5-HETE | KDO + ATP | 1.0 | BCD110605C08 | 1.28 | pmol/ml of medium |
| - | 5-HETE | KDO + ATP | 4.0 | BCD110605C25 | 1.98 | pmol/ml of medium |
| - | 5-HETE | KDO + ATP | 4.0 | BCD110605C26 | 2.48 | pmol/ml of medium |
| - | 5-HETE | KDO + ATP | 4.0 | BCD110605C27 | 2.45 | pmol/ml of medium |
| - | 5-HETE | KDO + ATP | 20.0 | BCD110605C45 | 1.64 | pmol/ml of medium |
| - | 5-HETE | KDO + ATP | 20.0 | BCD110605C43 | 1.66 | pmol/ml of medium |
| - | 5-HETE | KDO + ATP | 20.0 | BCD110605C44 | 1.72 | pmol/ml of medium |
| - | 5-HETE | C | 0.0 | BCD110605C02 | 0.619 | pmol/ml of medium |
| - | 5-HETE | C | 0.0 | BCD110605C01 | 0.615 | pmol/ml of medium |
| - | 5-HETE | C | 0.0 | BCD110605C03 | 0.562 | pmol/ml of medium |
| - | 5-HETE | C | 1.0 | BCD110605C06 | 0.463 | pmol/ml of medium |
| - | 5-HETE | C | 1.0 | BCD110605C05 | 0.482 | pmol/ml of medium |